The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors
Healthcare >> CEO Interviews >> June 29, 2015

Interview with the CEO and Director: Viveve Medical Inc. (VIVMF)

Patricia Scheller
Patricia Scheller is Chief Executive Officer and Director of Viveve Medical Inc. Ms. Scheller’s commitment to the health care industry spans more than 25 years. Prior to joining Viveve, she served as the CEO of Prescient Medical, Inc. — PMI — a privately held company that developed diagnostic imaging catheters and coronary stents designed to reduce deaths from heart attacks. Before PMI, she was the CEO of SomaLogic, a molecular diagnostic company dedicated to developing protein signature arrays. Ms. Scheller also managed several business units at Ortho-Clinical Diagnostics, a Johnson & Johnson company, and served in key executive positions at Dade Behring, a clinical diagnostics firm. In addition, she was Director of Cardiology Systems at Cordis, a Johnson & Johnson company renowned for pioneering vascular disease treatments. There, she was responsible for launching the PALMAZ-SCHATZ balloon-expandable stent, the first stent to achieve over a billion dollars in sales. Ms. Scheller received a B.S. in engineering degree in biomedical engineering from Duke University, and completed executive business education programs at Harvard University, Massachusetts Institute of Technology, Columbia University and Northwestern University.     Profile
TWST: Could you provide an overview of the company, including information about when you began?

Ms. Scheller: Viveve Medical is a company focused on women's health. The company was

Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
General Electric Company
Walmart Inc.
International Business Machines Corporation
Citigroup Inc.
Exxon Mobil Corporation
Bank of America Corporation
Dell Inc.
Verizon Communications Inc.
Alphabet Inc

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS
Interview with the CEO: Pasithea Therapeutics Corp. (NASDAQ:KTTA)
Interview with the CEO: BetterLife Pharma Inc. (OTCMKTS:BETRF)
Interview with the CEO: Cansortium Inc. (OTCMKTS:CNTMF)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
AI Opportunities Expand to Industrial, Utilities and Energy Sectors
India Fund Manager Expects Discretionary Spending to Grow
Inefficiency in Ex-US Markets Creates Opportunity to Buy at a Discount
ANALYST INTERVIEWS
Five Companies Dominate in Psychedelics-Based Drug Development
Cidara’s Long-Acting Antiviral Drug Could Be a Game Changer
Spotting Potential in the High-Risk, High Reward Neuroscience Space
Since 1963
© The Wall Street Transcript 2016, 2024
Terms and Conditions
Privacy Policy